Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.5 (EPT/RI) - Mediclinic International plc

8th Feb 2023 11:25

RNS Number : 3326P
UBS AG (EPT)
08 February 2023
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the Code)

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

UBS Investment Bank, London

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Mediclinic International plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Mediclinic International plc

(d) Date dealing undertaken:

07 February 2023

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

10p ordinary

Buy

 

170658

4.97298 GBP

4.96400 GBP

10p ordinary

Sell

 

175522

4.97298 GBP

4.96333 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

10p ordinary

CFD

 

Long

437

4.96823798627002 GBP

10p ordinary

CFD

 

Long

288

4.96920138888889 GBP

10p ordinary

CFD

 

Long

526

4.9655034 GBP

10p ordinary

CFD

 

Long

3

4.963333 GBP

10p ordinary

CFD

 

Long

15009

4.970005 GBP

10p ordinary

CFD

 

Long

18662

4.968635 GBP

10p ordinary

CFD

 

Long

551

4.964 GBP

10p ordinary

CFD

 

Long

1343

4.96796096 GBP

10p ordinary

CFD

 

Long

3821

4.97 GBP

10p ordinary

CFD

 

Long

3973

4.970288 GBP

10p ordinary

CFD

 

Long

32006

4.968 GBP

10p ordinary

CFD

 

Long

443

4.969503 GBP

10p ordinary

CFD

 

Long

190

4.971503 GBP

10p ordinary

CFD

 

Long

5744

4.968648 GBP

10p ordinary

CFD

 

Long

447

4.96749440715884 GBP

10p ordinary

CFD

 

Long

2206

4.96386219401632 GBP

10p ordinary

CFD

 

Long

1065

4.96385915492958 GBP

10p ordinary

CFD

 

Long

65

4.96753846153846 GBP

10p ordinary

CFD

 

Long

841

4.968647 GBP

10p ordinary

CFD

 

Long

2978

4.96823707186031 GBP

10p ordinary

CFD

 

Long

1971

4.96920852359209 GBP

10p ordinary

CFD

 

Short

12324

4.97 GBP

10p ordinary

CFD

 

Short

20620

4.969274 GBP

10p ordinary

CFD

 

Short

16985

4.964993 GBP

10p ordinary

CFD

 

Short

6000

4.97008666666667 GBP

10p ordinary

CFD

 

Short

1897

4.969715 GBP

10p ordinary

CFD

 

Short

2064

4.965701 GBP

10p ordinary

CFD

 

Short

2889

4.97207684 GBP

10p ordinary

CFD

 

Short

4093

4.964073 GBP

10p ordinary

CFD

 

Short

2190

4.972 GBP

10p ordinary

CFD

 

Short

2600

4.968 GBP

10p ordinary

CFD

 

Short

5733

4.964845 GBP

10p ordinary

CFD

 

Short

18713

4.964894 GBP

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none "

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

Date of disclosure:

08 February 2023

Contact name:

Richard Howard

Telephone number:

+44 (0)207 568 9128

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERTPMBTMTTMBIJ

Related Shares:

MDC.L
FTSE 100 Latest
Value8,275.66
Change0.00